Illumina Inc (NAS:ILMN)
$ 114.0435 -0.9665 (-0.84%) Market Cap: 18.17 Bil Enterprise Value: 19.49 Bil PE Ratio: 0 PB Ratio: 3.16 GF Score: 81/100

Illumina Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 05:40PM GMT
Release Date Price: $306.58 (+0.66%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

Thanks for joining us. My name is Mike Ryskin, I'm on the life science tools and diagnostics team here at Bank of America Merrill Lynch. I'm here on behalf of the senior analyst De Bruin, who unfortunately couldn't be here with us today but he sends his regards and he's following along via the webcast.

Joining us for the next session is Illumina, and here we're joined by Sam Samad. I think we'll start with about 20, 25 minutes of fireside chat and then we'll open up to the audience for Q&A. So I think there's a initial statement you got to give.

Sam A. Samad
Illumina, Inc. - CFO & Senior VP

Yes, the fun part. So thanks, Mike, first of all, for inviting us and pleasure to be here. Good morning, everybody. So I've been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot